- Home
- RIV vs TOI Comparison
RIV vs TOI Comparison
Compare RIV & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RIV | TOI |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.4M | 327.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RIV | TOI |
|---|---|---|
| Price | $12.01 | $3.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 87.6K | ★ 2.0M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 12.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $9.63 | $0.60 |
| 52 Week High | $12.43 | $4.88 |
Technical Indicators
Market Signals| Indicator | RIV | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 61.00 | 36.40 |
| Support Level | $11.79 | $3.30 |
| Resistance Level | $12.04 | $3.68 |
| Average True Range (ATR) | 0.09 | 0.27 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 84.71 | 1.00 |
Price Performance
Historical ComparisonAbout RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.